{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:37:15Z","timestamp":1791250635590,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ophtha.2009.12.038","type":"journal-article","created":{"date-parts":[[2010,4,26]],"date-time":"2010-04-26T04:37:45Z","timestamp":1272256665000},"page":"1538-1546.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":184,"title":["The Prevalence and Natural History of Dominant Optic Atrophy Due to OPA1 Mutations"],"prefix":"10.1016","volume":"117","author":[{"given":"Patrick","family":"Yu-Wai-Man","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailbhe","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Sellar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Gnanaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Ah-Kine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Czermin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick F.","family":"Chinnery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2009.12.038_bib1","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/sj.eye.6701570","article-title":"Molecular genetic basis of primary inherited optic neuropathies","volume":"18","author":"Votruba","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2009.12.038_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmg.2007.054270","article-title":"Inherited mitochondrial optic neuropathies","volume":"46","author":"Yu-Wai-Man","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.ophtha.2009.12.038_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/humu.20161","article-title":"eOPA1: an online database for OPA1 mutations","volume":"25","author":"Ferre","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ophtha.2009.12.038_bib4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/jmg.2008.062570","article-title":"Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy","volume":"46","author":"Fuhrmann","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.ophtha.2009.12.038_bib5","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1136\/jmg.2003.016576","article-title":"OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract","volume":"41","author":"Reynier","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.ophtha.2009.12.038_bib6","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1086\/324651","article-title":"Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews","volume":"69","author":"Anikster","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ophtha.2009.12.038_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1096-7192(02)00047-1","article-title":"3-methylglutaconic aciduria type III in a non-Iraqi-Jewish kindred: clinical and molecular findings","volume":"76","author":"Kleta","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ophtha.2009.12.038_bib8","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMp078040","article-title":"Mitochondrial dynamics in disease","volume":"356","author":"Chan","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2009.12.038_bib9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbabio.2009.02.024","article-title":"Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders","volume":"1787","author":"Carelli","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ophtha.2009.12.038_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jmg.35.10.793","article-title":"Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy","volume":"35","author":"Votruba","year":"1998","journal-title":"J Med Genet"},{"key":"10.1016\/j.ophtha.2009.12.038_bib11","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/hmg\/10.13.1369","article-title":"Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy","volume":"10","author":"Toomes","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ophtha.2009.12.038_bib12","first-page":"1715","article-title":"A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy","volume":"43","author":"Thiselton","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2009.12.038_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0420.2005.00448.x","article-title":"Dominant optic atrophy: correlation between clinical and molecular genetic studies","volume":"83","author":"Puomila","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2009.12.038_bib14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/bjo.2007.134726","article-title":"The natural history of OPA1-related autosomal dominant optic atrophy","volume":"92","author":"Cohn","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.12.038_bib15","doi-asserted-by":"crossref","first-page":"E692","DOI":"10.1002\/humu.21025","article-title":"Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations","volume":"30","author":"Ferre","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ophtha.2009.12.038_bib16","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1167\/iovs.05-0981","article-title":"Visual acuities \u201chand motion\u201d and \u201ccounting fingers\u201d can be quantified with the Freiburg Visual Acuity Test","volume":"47","author":"Schulze-Bonsel","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2009.12.038_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00417-008-0926-0","article-title":"Resolving the clinical acuity categories \u201chand motion\u201d and \u201ccounting fingers\u201d using the Freiburg Visual Acuity Test (FrACT)","volume":"247","author":"Lange","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.12.038_bib18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10545-005-0525-8","article-title":"OPA3 mutation screening in patients with unexplained 3-methylglutaconic aciduria","volume":"28","author":"Neas","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ophtha.2009.12.038_bib19","first-page":"4","article-title":"Genetic Risks: A Reference for Eye Care Practitioners","author":"Lyle","year":"1990"},{"key":"10.1016\/j.ophtha.2009.12.038_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0420.1996.tb00672.x","article-title":"Dominant optic atrophy mapped to chromosome 3q region","volume":"74","author":"Kjer","year":"1996","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2009.12.038_bib21","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s004390100600","article-title":"A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect","volume":"109","author":"Thiselton","year":"2001","journal-title":"Hum Genet"},{"key":"10.1016\/j.ophtha.2009.12.038_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/346066","article-title":"The epidemiology of Leber hereditary optic neuropathy in the North East of England","volume":"72","author":"Man","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ophtha.2009.12.038_bib23","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ajo.2006.12.038","article-title":"Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations","volume":"143","author":"Cohn","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.12.038_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/bjo.87.1.48","article-title":"Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy","volume":"87","author":"Votruba","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.12.038_bib25","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1001\/archopht.1979.01020020248013","article-title":"Dominant optic atrophy: the clinical profile","volume":"97","author":"Kline","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.12.038_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0161-6420(80)35247-0","article-title":"Autosomal dominant optic atrophy: a spectrum of disability","volume":"87","author":"Hoyt","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.12.038_bib27","first-page":"135","article-title":"Hereditary infantile optic atrophy with dominant transmission: preliminary report","volume":"3","author":"Kjer","year":"1956","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.ophtha.2009.12.038_bib28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0002-9394(14)73589-5","article-title":"Visual prognosis in autosomal dominant optic atrophy (Kjer type)","volume":"115","author":"Eliott","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.12.038_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.116.3.351","article-title":"Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy","volume":"116","author":"Votruba","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.12.038_bib30","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1167\/iovs.08-3166","article-title":"Quality of life in patients with Leber hereditary optic neuropathy","volume":"50","author":"Kirkman","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642009015139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642009015139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:00:24Z","timestamp":1758981624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642009015139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0161642009015139"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2009.12.038","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Prevalence and Natural History of Dominant Optic Atrophy Due to OPA1 Mutations","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2009.12.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}